Norbuprenorfin je primarni aktivni metabolit buprenorfina. Norbuprenorfin deluje kao pun agonist μ-opioidnog, δ-opioidnog, i nociceptinskog receptora,[1][2] kao i parcijalni agonist κ-opioidnog receptora.[2] Norbuprenorfin prolazi kroz krvno-moždanu barijeru slično buprenorfinu i verovatno doprinosi njegovom dejstvu.[3]
Vidi još [уреди]
Literatura [уреди]
- ^ Yassen A, Kan J, Olofsen E, Suidgeest E, Dahan A, Danhof M (May 2007). „Pharmacokinetic-pharmacodynamic modeling of the respiratory depressant effect of norbuprenorphine in rats“. The Journal of Pharmacology and Experimental Therapeutics 321 (2): 598–607. DOI:10.1124/jpet.106.115972. PMID 17283225.
- ^ а б Huang P, Kehner GB, Cowan A, Liu-Chen LY (May 2001). „Comparison of pharmacological activities of buprenorphine and norbuprenorphine: norbuprenorphine is a potent opioid agonist“. The Journal of Pharmacology and Experimental Therapeutics 297 (2): 688–95. PMID 11303059.
- ^ Jensen ML, Foster D, Upton R, Grant C, Martinez A, Somogyi A (April 2007). „Comparison of cerebral pharmacokinetics of buprenorphine and norbuprenorphine in an in vivo sheep model“. Xenobiotica; the Fate of Foreign Compounds in Biological Systems 37 (4): 441–57. DOI:10.1080/00498250701251126. PMID 17455115.
|
Molimo Vas, obratite pažnju na važno upozorenje
u vezi sa temama iz oblasti medicine (zdravlja). |